<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=489233&amp;fmt=gif">
Search
    Rebecca Beausang

    Rebecca Beausang

    Regulatory Affairs Specialist, Scilife

    Rebecca has over seven years of experience in medical device and other regulated industries. Alongside her expertise in FDA submissions, EU MDR compliance, and ISO 13485 QMS implementation, Rebecca is skilled in creating clear and impactful regulatory content. From technical documentation to compliance blogs, she excels in translating complex topics into engaging, actionable insights. Her passion lies in using compliance as a strategic tool to drive innovation and trust in regulated markets.

    More articles from Rebecca Beausang

    5 min read.

    7 warning signs your QMS is on the brink of failure and how to save it

    In the life sciences industry, a robust Quality Management System (QMS) is all-important for achieving compliance, sustaining operational efficiency, and safeguarding public trust. A QMS underpins every aspect of quality control, from adhering to str...

    Understanding FDA ISO 13485 and 21 CFR 820 harmonization

    As of February 2, 2026, the transition period for the Quality Management System Regulation (QMSR) has officially ended. The FDA now expects full compliance with this new framework, guaranteeing that FDA 21 CFR part 820 and ISO 13485 operate as one.

    Subscribe to the

    Scilife Blog

    Life Science and Quality resources and news. All directly to your inbox!

    Scilife Skyrocket microscope | Scilife